NADH fluorescence as a photobiological metric in 5-aminolevlinic acid (ALA)-photodynamic therapy

Optics Express

Volumn 19, Issue 22, 2011, Pages 21145-21154

  Su, Guan Chin ^a   Wei, Yau Huei ^a,b   Wang, Hsing Wen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; FLUORESCENCE; PLASMONS; POPULATION STATISTICS;

CASPASE-3; CELL VIABILITY; DIRECT APPROACH; DNA FRAGMENTATION; FLUENCE RATES; FLUENCES; IN-VITRO; NADH FLUORESCENCE; TIME COURSE;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL SURVIVAL; DRUG EFFECT; FLUORESCENCE; HUMAN; METABOLISM; NECROSIS; PHOTOBIOLOGY; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; RADIATION RESPONSE; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

AMINOLEVULINIC ACID; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLUORESCENCE; G1 PHASE; HUMANS; NAD; NECROSIS; PHOTOBIOLOGY; PHOTOCHEMOTHERAPY; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 80054931862     PISSN: None     EISSN: 10944087     Source Type: Journal    
DOI: 10.1364/OE.19.021145     Document Type: Article

References (28)

1. D. E. Dolmans, D. Fukumura, and R. K. Jain, "Photodynamic therapy for cancer", Nat. Rev. Cancer 3(5), 380-387 (2003). (Pubitemid 37328858)
2. B. C. Wilson, M. S. Patterson, and L. Lilge, "Implicit and explicit dosimetry in photodynamic therapy: a New paradigm", Lasers Med. Sci. 12(3), 182-199 (1997). (Pubitemid 27404122)
3. K. K.-H. Wang, S. Mitra, and T. H. Foster, "A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy", Med. Phys. 34(1), 282-293 (2007). (Pubitemid 46035250)
4. M. T. Jarvi, M. J. Niedre, M. S. Patterson, and B. C. Wilson, "Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects", Photochem. Photobiol. 82(5), 1198-1210 (2006). (Pubitemid 44701998)
5. M. J. Niedre, A. J. Secord, M. S. Patterson, and B. C. Wilson, "In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy", Cancer Res. 63(22), 7986-7994 (2003). (Pubitemid 37466737)
6. K. K. Wang, S. Mitra, and T. H. Foster, "Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals", Med. Phys. 35(8), 3518-3526 (2008).
7. S. Gross, A. Gilead, A. Scherz, M. Neeman, and Y. Salomon, "Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI", Nat. Med. 9(10), 1327-1331 (2003). (Pubitemid 37279859)
8. J. C. Finlay and T. H. Foster, "Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation", Med. Phys. 31(7), 1949-1959 (2004). (Pubitemid 38924813)
9. A. A. Stratonnikov and V. B. Loschenov, "Evaluation of blood oxygen saturation in vivo from diffuse reflectance spectra", J. Biomed. Opt. 6(4), 457-467 (2001). (Pubitemid 34220966)
10. G. Yu, T. Durduran, C. Zhou, H. W. Wang, M. E. Putt, H. M. Saunders, C. M. Sehgal, E. Glatstein, A. G. Yodh, and T. M. Busch, "Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy", Clin. Cancer Res. 11(9), 3543-3552 (2005). (Pubitemid 40627910)
11. B. Chen, B. W. Pogue, I. A. Goodwin, J. A. O'Hara, C. M. Wilmot, J. E. Hutchins, P. J. Hoopes, and T. Hasan, "Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor", Radiat. Res. 160(4), 452-459 (2003). (Pubitemid 37174513)
12. S. K. Bisland, L. Lilge, A. Lin, R. Rusnov, and B. C. Wilson, "Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors", Photochem. Photobiol. 80(1), 22-30 (2004).
13. A. Bogaards, A. Varma, K. Zhang, D. Zach, S. K. Bisland, E. H. Moriyama, L. Lilge, P. J. Muller, and B. C. Wilson, "Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development", Photochem. Photobiol. Sci. 4(5), 438-442 (2005). (Pubitemid 40740489)
14. B. W. Henderson, T. M. Busch, and J. W. Snyder, "Fluence rate as a modulator of PDT mechanisms", Lasers Surg. Med. 38(5), 489-493 (2006).
15. B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis, R. T. Cheney, and J. Morgan, "Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors", Cancer Res. 64(6), 2120-2126 (2004). (Pubitemid 38339462)
16. D. K. Bird, L. Yan, K. M. Vrotsos, K. W. Eliceiri, E. M. Vaughan, P. J. Keely, J. G. White, and N. Ramanujam, "Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH", Cancer Res. 65(19), 8766-8773 (2005). (Pubitemid 41377365)
17. M. C. Skala, K. M. Riching, A. Gendron-Fitzpatrick, J. Eickhoff, K. W. Eliceiri, J. G. White, and N. Ramanujam, "In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia", Proc. Natl. Acad. Sci. U. S. A. 104(49), 19494-19499 (2007).
18. H. W. Wang, Y. H. Wei, and H. W. Guo, "Reduced nicotinamide adenine dinucleotide (NADH) fluorescence for the detection of cell death", Anticancer. Agents Med. Chem. 9(9), 1012-1017 (2009).
19. H. W. Wang, V. Gukassyan, C. T. Chen, Y. H. Wei, H. W. Guo, J. S. Yu, and F. J. Kao, "Differentiation of apoptosis from necrosis by dynamic changes of reduced nicotinamide adenine dinucleotide fluorescence lifetime in live cells", J. Biomed. Opt. 13(5), 054011 (2008).
20. J. S. Yu, H. W. Guo, C. H. Wang, Y. H. Wei, and H. W. Wang, "Increase of reduced nicotinamide adenine dinucleotide fluorescence lifetime precedes mitochondrial dysfunction in staurosporine-induced apoptosis of HeLa cells", J. Biomed. Opt. 16(3), 036008 (2011).
21. H. W. Guo, Y. H. Wei, and H. W. Wang, "Reduced nicotinamide adenine dinucleotide fluorescence lifetime detected poly (adenosine-5'-diphosphate- ribose) polymerase-1-mediated cell death and therapeutic effect of pyruvate", J. Biomed. Opt. 16(6), 068001 (2011).
22. D. Grebenová, K. Kuželová, K. Smetana, M. Pluskalová, H. Cajthamlová, I. Marinov, O. Fuchs, J. Souček, P. Jarolím, and Z. Hrkal, "Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells", J. Photochem. Photobiol. B 69(2), 71-85 (2003). (Pubitemid 36336463)
23. N. L. Oleinick, R. L. Morris, and I. Belichenko, "The role of apoptosis in response to photodynamic therapy: what, where, why, and how", Photochem. Photobiol. Sci. 1(1), 1-21 (2002). (Pubitemid 37069701)
24. F. Giuntini, L. Bourré, A. J. MacRobert, M. Wilson, and I. M. Eggleston, "Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization", J. Med. Chem. 52(13), 4026-4037 (2009).
25. B. W. Pogue, J. D. Pitts, M. A. Mycek, R. D. Sloboda, C. M. Wilmot, J. F. Brandsema, and J. A. O'Hara, "In vivo NADH fluorescence monitoring as an assay for cellular damage in photodynamic therapy", Photochem. Photobiol. 74(6), 817-824 (2001).
26. H. W. Guo, C. T. Chen, Y. H. Wei, O. K. Lee, V. Gukassyan, F. J. Kao, and H. W. Wang, "Reduced nicotinamide adenine dinucleotide fluorescence lifetime separates human mesenchymal stem cells from differentiated progenies", J. Biomed. Opt. 13(5), 050505 (2008).
27. H. Okada and T. W. Mak, "Pathways of apoptotic and non-apoptotic death in tumour cells", Nat. Rev. Cancer 4(8), 592-603 (2004). (Pubitemid 39025054)
28. S. Elmore, "Apoptosis: a review of programmed cell death", Toxicol. Pathol. 35(4), 495-516 (2007). (Pubitemid 46911891)